Idat.i
Merge
Accueil
Racine
Merge
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration sur la méthode scrum - Merge (Accueil)

Index « Idat.i » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : Idat.i

Pour accéder à une entrée :

Les termes de plus forte occurence

30022-3549:1984:Hall I:hypolipidemic:activity:of
21434-6621:2009:Persijn J:a:new:method
21362-4393:2002:Silver J:the:impact:of
21328-8067:1965:Momma K:immunochemical:semiquantitative:estimation
20959-8138:1998:Brayne H:could:boxing:be
20954-7894:1994:Park H:occupational:asthma:caused
20954-7894:1993:Sears M:atopy:in:childhood
20954-7894:1991:Calkhoven P:relationship:between:igg
20926-9959:1996:Papadavid E:a:symmetrical:pustular
20904-2512:1973:Skaug N:proteins:in:fluid
20365-5555:1963:Haukenes G:serological:typing:of
20365-5555:1962:Hogman C:interaction:between:human
20365-5555:1949:Reyn A:serological:studies:on
20305-7453:1983:Bergan T:review:of:the
20302-9743:2007:Wijnands R:multi:tasking:agile
20302-9743:2006:During B:sprint:driven:development
20302-9743:2006:Dings Yr T:developing:software:with
20302-9743:2005:Pikkarainen M:an:approach:for
20302-9743:2004:Visconti M:an:ideal:process
20302-9743:2004:Kussmaul C:outsourcing:and:offshoring
20302-9743:2004:Conboy K:toward:a:conceptual
20302-9743:2004:Conboy K:agile:methods:the
20302-9743:2004:Bos E:an:agile:cmm
20302-9743:2003:Scotland K:agile:planning:with
20302-9743:2003:Jensen B:cross:continent:development
20278-5919:1998:Scher A:rugby:injuries:to
20264-0414:2000:Quarrie K:force:production:in
20256-9574:1999:Noakes T:an:apparent:reduction
20256-9574:1998:Jakoet I:a:high:rate
20248-4900:1991:Mahfoudi A:establishment:of:endometrial
20169-6009:1992:Van Holten A:palliative:pamidronate:treatment
20169-6009:1992:Grill V:circulating:pth:and
20169-6009:1992:Bekker P:risedronate:dose:response
20163-4453:1996:Skinner G:an:outbreak:of
20148-0227:2003:Allen S:on:vertical:advection
20140-6736:1986:Ludlam H:scrum:kidney:epidemic
20140-6736:1895:Tizzoni G:the:preparation:of
20112-1642:2002:Quarrie K:rugby:union:injuries
20093-691X:1997:Ohboshi S:effects:of:bovine
20044-4294:1956:Ubertini B:etudes:sur:la
20025-729X:2005:Carmody D:spinal:cord:injuries
20022-4731:1987:Gimenez Q E:probability:of:women
20022-3921:1989:Pesanti E:interaction:of:pneumocystis
20021-924X:1936:Sakakibara I:forschung:uber:die
20021-924X:1931:Toshima K:a:cold:hemotoxin
20021-924X:1930:Senshu J:some:investigations:on
20021-9150:1994:Cobbaert C:serum:lipoprotein:a
20021-8707:1965:Langlois C:the:allergic:response
20021-8707:1954:Portnoy J:complement:fixation:studies
20020-711X:1970:Farrell H:the:nature:of
20019-5456:1961:Rao H:nutrition:and:health
20019-2791:1978:Manak R:anti:sdna:antibody
20018-4888:2009:Pick K:proteinaceous:amylase:inhibitor
20014-4800:1979:Hollander W:lipoproteins:in:human
20009-2797:1973:Ellis B:the:effect:of
20008-6215:1983:Pal J:immunochemical:studies:on
20007-1323:1997:Kim Y:prediction:of:postoperative
20006-2928:1989:Mizuta K:biochemical:and:genetic
20006-2928:1985:De Looze M:biochemistry:and:genetics
20004-8291:1976:Muirden K:drug:interactions:in
20003-4975:1996:Jougon J:posterior:dislocation:of
20003-2670:1961:Kolthoff I:amperometric:argentimetric:and
18756-9728:2011:Aubry M:exploring:pmos:through
18756-9728:2009:Frame J:handbook:of:project
18756-9728:2008:Maylor H:managerial:complexity:in
18756-9728:2008:Frame J:reinventing:project:management
18756-9728:2008:Berggren C:lagomizing:organic:integration
18756-3282:2001:Chapurlat R:association:between:endogenous
18756-3282:1996:Anderson F:androgen:supplementation:in
18756-3282:1992:Shen V:lack:of:changes
18756-3282:1988:Lecanda F:impaired:intramembranous:bone
18755-7223::Scrum M:out:of:the
12329-4302:2014:Khademi A:generalized:method:for
12255-9086:2013:Berzisa S:project:phase:dependent
12239-9747:2014:Papalia R:rugby:and:shoulder
12194-6515:2012:Gilles M:tribal:rituals:of
12066-8732:2012:Bouchet P:comment:analyser:les
12050-2249:1896:Frankland P:the:work:of
12050-2249:1895:Frankland P:the:work:of
11941-5893:2012:Qureshi A:mobile:applications:for
11935-2611:2011:Balda J:adapting:leadership:theory
11933-7191:2007:Verheul H:levels:of:tibolone
11932-2054:2011:Rice G:book:review:analysis
11931-4973:2011:Yoshii A:analysis:of:the
11875-2136:2013:Chevalier L:athlete:s:heart
11868-1883:2010:Schindler A:progestogens:for:treatment
11755-6678:2011:Hobbs H:is:high:body
11752-8054:2010:Ellner J:immunoregulation:in:tb
11751-8806:2008:Salo O:agile:methods:in
11751-5521:2009:Lewis S:international:council:for
11746-5702:2008:Nicholson I:agile:skills:in
11746-5702:2005:Cowham R:to:xp:or
11744-3121:1976:B Rresen A:high:density:lipoprotein
11744-3091:2007:Mori T:crystallographic:characterization:of
11744-3091:2005:Saijo S:precipitation:diagram:and
11741-0398:2010:Loforte Ribeiro F:exploring:agile:methods
11741-0398:2004:Vidgen R:web:service:business
11741-0126:1991:Py B:cellulase:egz:of
11740-9705:2005:Eastaway R:how:to:take
11682-024X::M J:injury:incidence:and
11641-876X:2012:Colomo Palacios R:resyster:a:hybrid
11640-5544:2011:Lewandowska J:somatotype:variables:related
11615-9853:2010:Nouri M:comparative:analysis:of
11612-295X:2007:Pinker S:the:evolutionary:social
11600-4469:1997:Firoozkoohi J:comparison:of:lipopolysaccharides
11600-4469:1997:Das S:experimental:apexigenesis:in
11600-4469:1985:Barnett F:paget:s:disease
11590-8658:2000:Vecchi M:prevalence:clinical:correlates
11590-8658:2000:Rumi M:interferon:ribavirin:re
11590-8658:2000:Pezzilli R:time:course:of
11590-8658:2000:Di Campli C:parenchymal:damage:due
11566-5844:2001:Condoravdi C:clitics:and:clause
11556-4959:2008:Rauskolb F:caroline:an:autonomously
11555-0265:2008:Duffield R:the:effects:of
11553-7390:2015:Sano H:the:nutrient:responsive
11552-4825:2010:Thottungal A:caudal:dysgenesis:and
11540-7063:1973:Pang P:endocrine:control:of
11540-7063:1963:Schjeide O:liver:synthesis:plasma
11540-7063:1963:Barch S:regional:antigenig:differences
11532-060X:2011:Tolfo C:agile:methods:and
11532-060X:2011:Mishra D:complex:software:project
11532-060X:2010:Haapio T:software:project:effort
11532-060X:2010:Dzamashvili Fogelstrom N:the:impact:of
11532-060X:2009:Del Rosso C:comprehend:and:analyze
11532-060X:2006:Olague H:assessing:design:instability
11532-060X:2006:Del Rosso C:continuous:evolution:through
11532-060X:2003:Huffman Hayes J:observe:mine:adopt
11530-9827:2014:Vijayakumaran V:integrated:framework:for
11527-6465:2000:Russo Picasso M:antiresorptive:drugs:and
11527-6465:2000:Kizilisik T:years:of:chronic
11527-6465:2000:Kashyap R:causes:of:retransplantation
11527-6465:2000:Jain A:causes:of:death
11478-0542:2007:Watson G:sport:and:ethnicity
11475-9861:2002:Sugden T:shared:solutions:drivers
11472-0205:2008:Manning M:soft:tissue:injuries
11472-0205:2002:Andrews F:transient:cervical:neurapraxia
11471-9827:1990:Passmore R:how:many:benefits
11471-9827:1990:Kromhout D:n:fatty:acids
11471-6771:1981:Baraka A:neostigmine:and:atypical
11465-3249:1999:Muench M:requirement:of:retinoids
11464-7931:1958:Brambell F:the:passive:immunity
11464-7931:1954:Stewart D:the:liquid:medium
11464-7931:1950:Kayser P:le:sommeil:hibernal
11464-7931:1948:Chevremont P:le:systeme:histiocytaire
11464-7931:1934:Gerard P:esquisse:d:une
11463-6786:1965:Prest A:the:british:economy
11462-0324:1999:Torsteinsdottir I:serum:lysozyme:a
11462-0324:1996:M Ki Ikola O:similarly:increased:serum
11462-0324:1996:Johansen J:serum:ykl:levels
11462-0324:1996:Fex E:development:of:radiographic
11462-0324:1996:Bas S:the:value:of
11462-0324:1996:Averns H:radiological:outcome:in
11462-0324:1995:Tebib J:sil:r:levels
11462-0324:1995:Sood A:does:mixed:connective
11462-0324:1995:Sheeran T:hypocomplementaemia:c:nephritic
11462-0324:1995:Saraux A:the:antiperinuclear:factor
11462-0324:1995:Rahman M:proinflammaroty:role:of
11462-0324:1995:Nash M:anti:neutrophil:cytoplasmic
11462-0324:1995:Mijiyawa M:gout:in:patients
11462-0324:1995:M Ki Ikola O:antibodies:to:klesbsiella
11462-0324:1995:Fujimoto M:detection:of:antiribosomal
11462-0324:1994:Rai A:an:unusual:case
11462-0324:1990:Thompson P:synovial:fluid:and
11462-0324:1990:Mangat G:hypermobility:arthritis:and
11462-0324:1989:Melsom R:primary:meningococcal:arthritis
11462-0324:1989:Mckenna F:anaemia:and:rheumatoid
11462-0324:1989:Jenkinson M:rheumatold:arthritis:and
11462-0324:1989:Harats N:igg:rheumatoid:factor
11462-0324:1989:Doube A:drs:doube:and
11462-0324:1989:Campion G:serum:and:synovial
11462-0324:1988:Toivanen A:factors:associated:with
11462-0324:1988:Seideman P:equianalgesic:effects:of
11462-0324:1988:Schrieber L:an:evaluation:of
11462-0324:1988:Mody G:serum:creatinine:concentration
11462-0324:1988:Levesque H:serum:hyaluronate:in
11462-0324:1988:Hasselbacher P:serum:amylase:and
11462-0324:1988:Eggelmeijer F:pyomyositis:associated:with
11462-0324:1988:Doube A:anaemia:in:patients
11462-0324:1987:Wilmalaratna H:adenocarcinoma:of:the
11462-0324:1987:Simmons K:enhanced:chemotaxis:of
11462-0324:1987:Ralston S:macrocytosis:and:sulphasalazine
11462-0324:1987:Klimiuk P:ibuprofen:does:not
11462-0324:1987:Keane A:anticardiolipin:antibodies:in
11462-0324:1987:Kanterewicz E:iga:nephropathy:in
11462-0324:1987:Kalra L:lymphoreticular:malignancy:and
11462-0324:1987:Evison G:comparison:of:erect
11462-0324:1987:Burns H:gold:induced:hypogammaglobulinaemia
11462-0324:1987:Berczi I:decreased:bioactivity:of
11462-0324:1987:Beaman M:rheumatoid:arthritis:and
11462-0324:1985:Woolf A:interleukin:and:the
11462-0324:1985:Whicher J:decreased:production:of
11462-0324:1985:Townsend Y:the:pyrogenic:properties
11462-0324:1985:Saklatvala J:purification:of:pig
11462-0324:1985:Saklatvala J:an:antiserum:to
11462-0324:1985:Moldawer L:a:therapeutic:use
11462-0324:1985:Kupper T:in:vivo:exposure
11462-0324:1985:Knudsen P:elevated:intracellular:camp
11462-0324:1985:Kimball E:absence:of:pyrogenicity
11462-0324:1985:Cannon J:multiple:interleukin:activities
11462-0324:1985:Billingham M:interleukin:its:relevance
11462-0324:1983:Eastmond C:gram:negative:bacteria
11462-0324:1982:Bentley D:parenteral:iron:theraphy
11460-2725:1992:Kanabrocki E:a:quest:for
11460-2725:1989:Willcox N:variable:corticosteroid:sensitivity
11460-2725:1989:Leak A:autoimmune:rheumatic:disorders
11460-2725:1989:Farci P:treatment:of:chronic
11460-2725:1987:Gray R:duration:of:effect
11460-2725:1985:Walker R:clinical:and:morphological
11460-2725:1984:Turgan C:the:effect:of
11460-2725:1984:Sandler L:studies:of:the
11460-2725:1984:Kanis J:should:we:use
11460-2725:1983:Ramos J:continuous:ambulatory:peritoneal
11460-2725:1983:Neild G:rapidly:progressive:glomerulonephritis
11460-2725:1982:Solomon L:bartter:s:syndrome
11460-2725:1981:Tarantino A:renal:disease:in
11460-2725:1981:Nicholls A:lipid:relationships:in
11460-2725:1981:Mcconnell J:use:of:liver
11460-2725:1979:Hansen H:chronic:interstitial:nephropathy
11460-2725:1977:Lim P:calcium:and:phosphorus
11460-2725:1977:Carmalt M:the:treatment:of
11460-2725:1976:Roberts S:intestinal:lymphangiectasia:the
11460-2725:1976:Mcintosh R:the:nature:and
11460-2725:1976:Davis J:diaphragm:function:and
11460-2725:1976:Cream J:clinical:and:immunological
11460-2725:1968:Hoffbrand A:megaloblastic:anaemia:in
11460-2725:1966:Turnberg L:the:absorption:of
11460-2725:1959:Stanbury S:salt:wasting:renal
11460-2725:1927:Clark Kennedy A:the:limitation:of
11460-2725:1927:Christie R:studies:in:blood
11460-2725:1913:Browning C:critical:review:haemolysis
11460-2725:1912:Gordon M:critical:review:the
11460-2725:1911:Windsor J:the:bacteriology:of
11460-2725:1911:Wallis R:on:chylous:and
11460-2725:1909:Hawkins H:congenital:family:cholaemia
11445-1433:2004:Boyle F:cancer:communicating:in
11440-2440:2009:Gianotti S:evaluation:of:rugbysmart
11440-2440:1999:H M:head:and:neck
11439-9598:2003:Heinemann S:zellschleusen:nmr:bilder
11439-4227:2011:Endoh:gene:regulation:system
11434-6621:2012:Huijuan Wang:evidence:for:serum
11434-6621:2009:Wood W:an:evaluation:of
11434-6621:2009:Wood W:a:comparison:of
11434-6621:2009:Wombacher H:a:simple:competitive
11434-6621:2009:Wijnen P:capillary:electrophoresis:of
11434-6621:2009:Wiedemann G:reference:ranges:for
11434-6621:2009:Wider G:evaluation:of:a
11434-6621:2009:Weykamp C:evaluation:of:a
11434-6621:2009:Werner M:influence:of:sex
11434-6621:2009:Weicker H:die:bedeutung:von
11434-6621:2009:Vonderschmitt D:teststreifen:fur:screening
11434-6621:2009:Vester B:high:performance:liquid
11434-6621:2009:Versieck J:determination:of:manganese
11434-6621:2009:Van Noort W:purification:of:isotransferrins
11434-6621:2009:Van Der Kooij P:determination:of:serum
11434-6621:2009:Turek S:albumin:turbidity:reaction
11434-6621:2009:Sugahara K:measurement:of:iminodipeptides
11434-6621:2009:Struck H:klinisch:chemische:befunde
11434-6621:2009:Stamm D:reference:materials:and
11434-6621:2009:Scholer A:evaluation:of:a
11434-6621:2009:Schlaeger R:the:mechanism:of
11434-6621:2009:Salem R:non:separation:radioassay
11434-6621:2009:Prellwitz W:vergleichende:methoden:zur
11434-6621:2009:Pilz W:fermente:des:menschlichen
11434-6621:2009:Persijn J:application:of:haemagglutination
11434-6621:2009:Paschen K:determination:of:potassium
11434-6621:2009:Ondrus P:importance:of:lipid
11434-6621:2009:Nielsen I:a:gel:filtration
11434-6621:2009:Meltzer H:oral:intake:of
11434-6621:2009:Meinhold H:radioimmunoassay:of:triiodo
11434-6621:2009:Markianos E:serum:dopamine:hydroxylase
11434-6621:2009:Lopes Pereira C:use:of:the
11434-6621:2009:Lippi G:effects:of:anticoagulants
11434-6621:2009:Lewin L:alkaline:phosphatase:in
11434-6621:2009:Leto G:cathepsin:d:serum
11434-6621:2009:Lang W:flammenspektrophotometrische:methode:zur
11434-6621:2009:Lamerz R:zur:quantitativen:immunologischen
11434-6621:2009:Kuffer H:die:bestimmung:des
11434-6621:2009:Kruskemper H:thyroxinbindungskapazit:und:jodgehalt
11434-6621:2009:Kropf J:the:prognostic:value
11434-6621:2009:Ko Ent A:the:diagnostic:value
11434-6621:2009:Knoll E:abh:der:konzentrationen
11434-6621:2009:Keler Ba Oka M:the:specific:property
11434-6621:2009:Kattermann R:simultanmethode:fur:die
11434-6621:2009:Kaiser E:uber:steroid:konjugate
11434-6621:2009:Jung K:multiple:forms:of
11434-6621:2009:Jung K:an:optimized:micromethod
11434-6621:2009:Josi D:isolation:of:immunoglobulins
11434-6621:2009:Ising H:measurement:of:free
11434-6621:2009:Ideo G:mitochondrial:aspartate:aminotransferase
11434-6621:2009:Horn K:semiautomatic:method:for
11434-6621:2009:Harff G:albumin:determination:with
11434-6621:2009:Guiguet M:laser:nephelometric:measurement
11434-6621:2009:Gressner A:evaluation:of:the
11434-6621:2009:Gressner A:amidolytic:and:immuno
11434-6621:2009:Goebelsmann U:separation:of:cystine
11434-6621:2009:Gladtke E:die:bilirubinbestimmung:nach
11434-6621:2009:Falk U:radioimmunoassay:for:serum
11434-6621:2009:Estborn B:separation:of:phosphatase
11434-6621:2009:Eder G:a:longitudinal:study
11434-6621:2009:Ebeling H:eine:optimierte:automatische
11434-6621:2009:Dwenger A:zum:einflu:von
11434-6621:2009:Dikow A:isoenzyme:der:fructose
11434-6621:2009:Delanghe J:measurement:of:activation
11434-6621:2009:Croci D:a:simple:immunoturbidimetric
11434-6621:2009:Costongs G:evaluation:of:performance
11434-6621:2009:Buti M:digoxygenin:labelled:dna
11434-6621:2009:Boyde T:detection:and:assay
11434-6621:2009:Bollengier F:measles:antibodies:anti
11434-6621:2009:Bollengier F:bound:and:free
11434-6621:2009:Assink H:the:influence:of
11407-7493:2011:Cernickins A:on:foundation:for
11407-7493:2010:B Rzisa S:the:baseline:configuration
11388-9842:2000:Paterna S:effects:of:high
11388-2481:2006:Wang X:development:of:a
11386-6532:2000:Wu L:human:herpesvirus:glycoprotein
11386-6346:2009:Yao X:protective:effect:of
11383-5769:1998:Itoh M:urino:diagnosis:of
11383-5769:1998:Hassi A:current:diagnosis:of
11368-6267:1994:Collins E:the:writing:on
11367-7543:2007:Khanna K:pathophysiology:and:treatment
11367-4803:1993:Sakamoto N:development:of:the
11363-3554:1990:Newsinger J:reviews:and:enthusiasms
11363-254X:1997:Harrison S:earning:trust:by
11360-8592:1998:Latey P:the:pressures:of
11360-2276:1998:Geissler P:geophagy:iron:status
11359-6101:1997:Takatsu K:interleukin:and:b
11357-8170:1996:Parfitt V:effects:of:moderate
11357-8170:1992:Raman:the:nature:and
11357-8170:1991:Abdulla:the:management:of
11357-8170:1989:Watts:serum:fructosamine:and
11357-8170:1989:Brooks:safe:changeover:to
11357-2725:1997:Marshall R:the:pathogenesis:of
11356-1294:2000:Humphrey C:in:the:eye
11355-6215:2003:Sobczak A:the:effects:of
11355-6037:1998:Somerville J:the:master:s
11355-557X:2010:Gang L:effect:of:density
11355-557X:1990: Ehulka J:effect:of:hydrolytically
11355-557X:1989: Ehulka J:determining:the:optimum
11354-5078:2005:Gill F:public:and:private
11353-8047:2012:Camden A:the:impact:of
11353-8047:2003:Pless I:guest:editorials:commentaries
11353-8047:2003:Abernethy L:immediate:care:of
11353-8047:2002:Lyons R:development:and:use
11353-8047:2002:Kuhn E:missing:the:target
11353-8047:1995:Munro J:can:we:prevent
11353-4505:1996:Ansari M:establishing:thresholds:for
11352-7606:2000:Tixier M:communication:and:management
11351-5101:1995:Johannsen P:methylmalonic:acid:in
11350-1917:2011:White Baker E:why:situational:method
11350-1917:2010:Ramesh B:agile:requirements:engineering
11350-1917:2009:Berger H:the:utility:of
11350-1917:2004:Baskerville R:short:cycle:time
11344-3941:2009:Isobe N:immunolocalization:of:lingual
11344-3941:2006:Klinhom P:effect:of:restricted
11330-1012:2009:Arias Peixoto C:human:computer:interface
11328-8067:1998:Tazawa Y:neonatal:intrahepatic:cholestasis
11328-8067:1998:Iwata F:coronary:risk:factors
11328-8067:1998:I Slcan A:low:levels:of
11328-8067:1998:Bonno M:acute:myositis:with
11328-8067:1995:Rabinovitch M:elastase:and:cell
11328-8067:1994:Iyori H:lymphoma:syndrome:leukemia
11328-8067:1992:Yeung C:effect:of:serum
11328-8067:1959:Shichiro A:studies:on:metabolism
11328-8067:1958:Suzuki M:studies:on:ultrafiltrable
11328-0163:1996:Tonkin A:cholesterol:and:coronary
11320-5463:1983:Toda T:the:role:of
11320-5463:1983:Ishihara T:foamy:cells:in
11320-5463:1967:Ozawa H:histopathology:of:liver
11320-5463:1959:Shoji Y:an:autopsy:case
11320-5463:1959:Ozawa H:an:autopsy:case
11318-5454:2010:Mahni V:teaching:scrum:in
11265-1397:2011:Memmi G:deux:retours:d
11265-1397:2011:Bagane H:principes:de:genie
11239-9736:1998:Luoma P:antioxidants:infections:and
11176-9114:2016:Zidan A:nicotinamide:polymeric:nanoemulsified
11170-229X:2003:Bang L:pravastatin:a:review
11102-4151:2002:Alhan E:effects:of:the
11098-1241:2011:Azizian N:a:framework:for
11096-6080:1998:Burns Naas L:inhalation:toxicology:of
11096-6080:1998:Bojes H:bcl:and:bcl
11096-6080:1995:Greene D:effects:of:dihydrotestosterone
11096-6080:1994:Pestka J:progressive:serum:ige
11096-6080:1994:Odio M:evaluation:of:subchronic
11096-6080:1994:Levier D:immunotoxicological:profile:of
11096-6080:1991:Tryphonas H:effect:of:chronic
11096-6080:1990:Schop R:comparison:of:the
11096-6080:1986:Nau H:vaiproic:acid:teratogenicity
11096-6080:1986:Daniel F:genotoxic:properties:of
11096-6080:1984:Slighter R:comparative:nephrotoxidty:of
11096-6080:1984:Johnson D:reproductive:toxicological:evaluation
11096-6080:1984:Goethals F:critical:biochemical:functions
11096-6080:1984:Fort F:heinz:bodies:methemoglobinemia
11096-6080:1984:Clifford Conaway C:subchronic:inhalation:toxicity
11096-6080:1984:Butcher R:behavioral:and:physical
11091-6660:1997:Yamawaki T:can:immunoadsorption:plasmapheresis
11090-8471:2009:Mishra D:effective:communication:collaboration
11090-8471:2005:Paez O:moving:from:lean
11089-7801:2014:Tsai W:cloud:based:software
11088-1980:2011:Jensen P:reinterpreting:industrial:ecology
11087-8572:2010:Denning S:a:leader:s
11083-8791:2001:Hahn T:the:role:of
11077-4866:2008:Tomaszewski P:from:traditional:to
11077-4866:2008:Taylor P:preparing:small:software
11077-4866:2008:Suscheck C:jazz:improvisation:as
11077-4866:2008:Paasivaara M:using:scrum:in
11077-4866:2008:Larrucea X:method:engineering:approach
11077-4866:2008:Kettunen P:combining:agile:software
11077-4866:2008:Damian D:global:software:development
11077-4866:2008:Dalcher D:managing:software:processes
11077-4866:2007:Salo O:an:iterative:improvement
11077-4866:2007:Kettunen P:extending:software:project
11077-4866:2007:Bowers A:adoption:of:xp
11074-5521:1998:Huang C:lipitoids:novel:cationic
11071-2690:1996:Moberg L:keith:porter:and
11071-2690:1993:Cianciarulo L:effects:of:tumor
11066-5234:2003:Dunnebacke T:isolation:of:balamuthia
11066-5234:1995:Von Kreuter B:attenuation:of:parasite
11064-8011:2007:Wu W:an:investigation:of
11059-7794:1994:Poulat F:description:and:functional
11059-7794:1994:Jacobson D:a:double:variant
11059-1478:2011:Narayanan S:managing:outsourced:software
11058-8183:1996:Silva L:assessment:of:ovarian
11058-8183:1994:Grooters A:sonographic:appearance:of
11058-4838:2009:Wasserzug O:a:cluster:of
11058-4838:1995:Davies H:evaluation:of:short
11058-4838:1994:Williams W:identification:of:rickettsia
11058-0530:2006:Holmstrom H:agile:practices:reduce
11054-139X:1994:Rodman J:pharmacokinetic:variability:in
11054-139X:1993:Lipnick R:neurosarcoidosis:presenting:as
11054-139X:1991:Veit B:serological:response:to
11054-139X:1991:Rowland T:iron:deficiency:in
11053-1858:2006:Lynn L:the:performance:of
11053-0770:1994:Umbrain V:intraoperative:coronary:thrombosis
11053-0770:1994:Nathan N:serum:platelet:activating
11053-0770:1994:Casthely P:magnesium:and:arrhythmias
11053-0770:1991:Knopes K:con:magnesium:is
11051-0443:1999:Waybill P:arterial:and:venous
11050-642X:2005:Comstock R:protective:equipment:use
11050-642X:1996:O Brien C:quot:rugby:neck
11047-3211:1995:Vaccarino F:basic:fibroblast:growth
11047-3211:1994:Ojima H:terminal:morphology:and
11047-2797:1997:Shaten B:lung:cancer:mortality
11047-2797:1996:Iribarren C:correlates:of:uric
11047-2797:1996:Clark P:response:error:in
11047-1987:2007:Spirling A:bayesian:approaches:for
11045-3873:2000:Kubota T:hypokalemia:induced:long
11045-3873:1999:Tan H:long:term:subacute
11045-3873:1996:Platt S:occult:t:wave
11045-3873:1993:Vereckei A:the:role:of
11045-3873:1990:Turgeon J:effects:of:drug
11045-3873:1990:Love J:the:role:of
11043-4666:1994:Zurawski S:the:receptors:for
11043-4666:1994:Van Damme J:identification:of:bovine
11043-4666:1994:Sun Y:isolation:and:expression
11043-4666:1994:Berger R:a:fibroblast:growth
11043-2760:1989:Mendelson C:regulation:of:pulmonary
11042-0533:1996:Ellison P:developmental:influences:on
11040-0397:1994:Deng J:fish:liver:tissue
11036-7314:2000:Schmitz K:providing:the:best
11035-8811:2006:Noszlopy L:the:schapelle:corby
11035-7319:1992:Leeder:valuable:health:what
11035-6851:1991:Hore C:flaccid:paralysis:due
11034-4810:1971:Leonard R:serum:lipoproteins:in
11028-8880:2011:Pourfallah F:evaluation:of:serum
11011-1344:1996:Von Laar J:carotene:serum:levels
11011-1344:1996:Gillies R:spectral:characterization:of
11011-1344:1994:Ambroz M:time:resolved:fluorescence
11000-2588:2004:Li J:effects:of:kidney
10969-806X:1994:Lombardo J:sera:radiosterilization:studies
10969-8051:1995:Szucs M:lyophilization:and:rehydration
10968-6673:2003:Newsome K:the:women:can
10968-6673:2000:Smith C:notes:from:the
10968-5227:2010:Goldstein Z:finding:middle:ground
10968-0896:1996:Wilde R:acat:inhibitors:derived
10968-0896:1996:Taylor W:quiescent:affinity:inactivators
10968-0896:1996:Scott A:travels:of:an
10968-0004:1979:Haigler H:epidermal:growth:factor
10966-842X:1996:Matthews R:antibodies:against:candida
10966-842X:1996:Cheers C:how:do:macrophages
10966-842X:1994:Radolf J:role:of:outer
10966-842X:1994:Philipp M:animal:models:of
10966-842X:1994:Elsbach P:integration:of:antimicrobial
10966-3274:2001:Takatsuki M:analysis:of:alloreactivity
10966-0429:1993:Massey P:hoapital:closure:a
10964-9425:1997:Smith C:gender:issues:in
10964-9425:1994:Smith C:addressing:gender:issues
10964-6906:1992:Oakey R:construction:of:a
10964-2633:1981:Leeming R:the:role:of
10964-2633:1980:Barkin R:phagocytic:function:in
10964-2633:1979:Veall R:the:borjeson:forssman
10964-2633:1978:Franceschi C:t:and:b
10964-2633:1977:Gershwin M:immunologic:characteristics:of
10964-2633:1977:Barden H:vitamin:a:and
10964-2633:1976:Nishida Y:a:case:of
10964-2633:1975:Veall R:a:profoundly:mentally
10964-2633:1975:Primrose D:epiloia:in:twins
10964-2633:1974:Butler L:a:retarded:child
10964-2633:1973:Palo J:free:amino:acids
10964-2633:1972:Viukari N:low:serum:calcium
10964-2633:1972:Bain A:sandhoff:s:disease

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Informatique/explor/Scrum.storage/ScrumV1/Data/Main/Merge/Idat.i.hfd| SxmlCut idx/l | grep ...
Wicri

This area was generated with Dilib version V0.6.39.
Data generation: Tue Mar 5 18:28:08 2024. Site generation: Tue Mar 5 18:45:01 2024